AT4 receptor structure-binding relationship: angiotensin IV analogues

Baker, 1990, Angiotensin II stimulation of protein synthesis and cell growth in chick heart cells, Am. J. Physiol., 259, H610

Braszko, 1988, Angiotensin II (3–8) hexapeptide affects motor activity, performance of passive avoidance and conditioned avoidance response in rats, Neuroscience, 27, 777, 10.1016/0306-4522(88)90182-0

Coleman, 1992, Changes in renal blood flow due to infusions of angiotensin II (3–8) [AIV] in normotensive rats, FASEB J., 6, A981

Coleman, 1993, Changes in renal blood flow due to infusions of angiotensin II (3–8) [Ang IV] and its peptide analogs lysine1 Ang IV and norleucine1 AIV

Glossman, 1974, Properties of angiotensin II receptors in the bovine and rat adrenal cortex, J. Biol. Chem., 249, 825, 10.1016/S0021-9258(19)43003-2

Harberl, 1991, Angiotensin degradation products mediate endothelium-dependent dilation of rabbit brain arterioles, Circ. Res., 68, 1621, 10.1161/01.RES.68.6.1621

Hall, 1992, Characterization of a specific binding site for the hexapeptide fragment of angiotensin II (AIV) in cultured bovine vascular cells, FASEB J., 6, A1822

Hanesworth, 1993, Elucidation of a specific binding site for angiotensin II (3–8), angiotensin IV, in mammalian heart membranes, J. Pharmacol. Exp. Ther., 266, 1036

Harding, 1992, Identification of an AII (3–8) [AIV] binding site in guinea pig hippocampus, Brain Res., 583, 340, 10.1016/S0006-8993(10)80047-2

Jarvis, 1992, The angiotensin hexapeptide 3–8 fragment potently inhibits [125I] angiotensin II binding to non AT1 or-AT2 recognition sites in bovine adrenal cortex, Eur. J. Pharmacol., 219, 319, 10.1016/0014-2999(92)90312-R

Kaiser, 1970, Color test for detection of free terminal amine groups in the solid-phase synthesis of peptides, Anal. Biochem., 34, 595, 10.1016/0003-2697(70)90146-6

Lowry, 1951, Protein measurement with the Folin phenol reagent, J. Biol. Chem., 193, 265, 10.1016/S0021-9258(19)52451-6

Miller-Wing, 1993, Central angiotensin IV receptors, distribution and specificity in guinea pig brain, J. Pharmacol. Exp. Ther., 266, 1718

Munson, 1980, LIGAND: A versatile computerized approach to characterization of ligand binding systems, Anal. Biochem., 107, 220, 10.1016/0003-2697(80)90515-1

Sardinia, 1993, AT4 receptor binding characteristics: d-amino acid and glyche-substituted peptides, Peptides, 14, 949, 10.1016/0196-9781(93)90071-N

Sasaki, 1987, Solid phase synthesis of peptides containing the CH2NH peptide bond isostere, Peptides, 8, 119, 10.1016/0196-9781(87)90174-4

Semple, 1976, Angiotensin II and its heptapeptide (2–8), hexapeptide (3–8), and pentapeptide (4–8) metabolites in arterial and venous blood of main, Circ. Res., 39, 671, 10.1161/01.RES.39.5.671

Swanson, 1992, Discovery of a distinct binding site for angiotensin II (3–8), a putative angiotensin IV receptor, Regul. Pept., 40, 400, 10.1016/0167-0115(92)90527-2

Swanson, 1992, Solubilization of a new angiotensin receptor subtype from bovine adrenals, FASEB J., 6, A1576

Timmermans, 1991, Nonpeptide angiotensin II receptor antagonists, Trends Pharmacol. Sci., 12, 55, 10.1016/0165-6147(91)90498-H

Whitebread, 1989, Preliminary biochemical characterization of two angiotensin II receptor subtypes, Biochem. Biophys. Res. Commun., 163, 284, 10.1016/0006-291X(89)92133-5

Wright, 1993, Angiotensin II (3–8) (Ang IV) hippocampal binding: Potential role in the facilitation of memory, Brain Res. Bull., 32, 492, 10.1016/0361-9230(93)90297-O